MDNA
Medicenna Therapeutics Corp. Common Shares
MDNA
MDNA
Delisted
MDNA was delisted on the 1st of November, 2023.
25 hedge funds and large institutions have $2.41M invested in Medicenna Therapeutics Corp. Common Shares in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$97.1K | |
| 2 | +$16.2K | |
| 3 | +$7.9K | |
| 4 |
Millennium Management
New York
|
+$7.14K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$6.4K |
Top Sellers
| 1 | -$318K | |
| 2 | -$19K | |
| 3 | -$12.3K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$9.75K |
| 5 |
NDSI
Newman Dignan & Sheerar Inc
Providence,
Rhode Island
|
-$6.22K |